Body and Mind Inc. Updates Progress in Filing Financial Statements
Body and Mind Inc. (CSE: BAMM, OTC Pink: BMMJ) has provided an update regarding the delay in filing its annual financial statements for the fiscal year ended July 31, 2024. The company reports that while the audit process is substantially complete, there are remaining final procedures to be completed, including: approval of an external accounting memorandum, potential additional audit procedures for independent conclusions, and final internal quality control sign-off from the auditor.
The company is actively working with auditors to complete the 2024 Annual Financial Filings, which include management discussion and analysis along with CEO and CFO certifications. Updates will continue to be provided in accordance with National Policy 12-203 Management Cease Trade Orders.
Body and Mind Inc. (CSE: BAMM, OTC Pink: BMMJ) ha fornito un aggiornamento riguardo al ritardo nella presentazione dei suoi bilanci annuali per l'anno fiscale chiuso il 31 luglio 2024. L'azienda riferisce che, sebbene il processo di audit sia sostanzialmente completato, ci sono ancora procedure finali da completare, tra cui: approvazione di un memorandum contabile esterno, potenziali procedure di audit aggiuntive per conclusioni indipendenti e approvazione finale del controllo di qualità interno da parte del revisore.
L'azienda sta lavorando attivamente con i revisori per completare le dichiarazioni finanziarie annuali del 2024, che includono la discussione e l'analisi della direzione insieme alle certificazioni del CEO e del CFO. Gli aggiornamenti continueranno ad essere forniti in conformità con la Politica Nazionale 12-203 sugli Ordini di Arresto della Gestione.
Body and Mind Inc. (CSE: BAMM, OTC Pink: BMMJ) ha proporcionado una actualización sobre el retraso en la presentación de sus estados financieros anuales para el año fiscal que terminó el 31 de julio de 2024. La empresa informa que, aunque el proceso de auditoría está sustancialmente completo, aún quedan procedimientos finales por completar, incluyendo: la aprobación de un memorando contable externo, posibles procedimientos de auditoría adicionales para conclusiones independientes y la aprobación final del control de calidad interno por parte del auditor.
La empresa está trabajando activamente con los auditores para completar las Declaraciones Financieras Anuales 2024, que incluyen la discusión y análisis de la dirección junto con las certificaciones del CEO y CFO. Se continuarán proporcionando actualizaciones de acuerdo con la Política Nacional 12-203 sobre Órdenes de Detención de Gestión.
Body and Mind Inc. (CSE: BAMM, OTC Pink: BMMJ)는 2024년 7월 31일에 종료된 회계연도의 연간 재무제표 제출 지연에 대한 업데이트를 제공했습니다. 회사는 감사 프로세스가 실질적으로 완료되었지만, 외부 회계 메모 승인, 독립적인 결론을 위한 추가 감사 절차 가능성 및 감사자가 제공하는 내부 품질 관리 승인 등 최종 절차가 남아 있다고 보고했습니다.
회사는 2024년 연간 재무 filings를 완료하기 위해 감사인과 적극적으로 협력하고 있으며, 여기에는 경영진의 논의 및 분석과 CEO 및 CFO의 인증이 포함됩니다. 업데이트는 12-203호 국가 정책에 따라 계속 제공될 예정입니다.
Body and Mind Inc. (CSE: BAMM, OTC Pink: BMMJ) a fourni une mise à jour concernant le retard dans le dépôt de ses états financiers annuels pour l'exercice fiscal clos le 31 juillet 2024. L'entreprise rapporte que, bien que le processus d'audit soit essentiellement terminé, il reste des procédures finales à accomplir, notamment : l'approbation d'un mémo comptable externe, d'éventuelles procédures d'audit supplémentaires pour des conclusions indépendantes et l'approbation finale du contrôle qualité interne par l'auditeur.
L'entreprise travaille activement avec les auditeurs pour terminer les dépôts financiers annuels de 2024, qui incluent la discussion et l'analyse de la direction ainsi que les certifications du PDG et du directeur financier. Des mises à jour continueront d'être fournies conformément à la Politique nationale 12-203 relative aux ordres d'arrêt de gestion.
Body and Mind Inc. (CSE: BAMM, OTC Pink: BMMJ) hat ein Update zur Verzögerung bei der Einreichung seiner Jahresabschlüsse für das am 31. Juli 2024 endende Geschäftsjahr bereitgestellt. Das Unternehmen berichtet, dass der Prüfungsprozess zwar im Wesentlichen abgeschlossen ist, aber noch einige Abschlussverfahren ausstehen, darunter: die Genehmigung eines externen Buchhaltungsprotokolls, mögliche zusätzliche Prüfungsverfahren für unabhängige Rückschlüsse und die endgültige interne Qualitätskontrolle durch den Prüfer.
Das Unternehmen arbeitet aktiv mit den Prüfern zusammen, um die Jahresabschlüsse 2024 abzuschließen, die die Diskussion und Analyse durch das Management sowie die Zertifizierungen des CEO und CFO umfassen. Aktualisierungen werden weiterhin gemäß der nationalen Richtlinie 12-203 zu Handelsstopps des Managements bereitgestellt.
- None.
- Delayed filing of 2024 annual financial statements
- Incomplete audit process affecting regulatory compliance
- Potential risk of trading restrictions due to delayed filings
Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - January 20, 2025) - Body and Mind Inc. (CSE: BAMM) (OTC Pink: BMMJ) (the "Company" or "BaM") is providing an update regarding its delayed annual financial statements for the year ended July 31, 2024, including the related management discussion and analysis and CEO and CFO certifications (collectively, the "2024 Annual Financial Filings").
Although the audit process is substantially complete, the additional final procedures include (i) final approval of an external accounting memorandum for the auditor, (ii) application of additional audit procedures (as needed) to assess independent conclusions, and (iii) final internal QC sign-off from the auditor.
The Company and auditors are working closely to complete the 2024 Annual Financial Filings and will continue to provide updates in accordance with National Policy 12-203 Management Cease Trade Orders.
About Body and Mind Inc.
BaM is an operations-focused cannabis company which operates retail cannabis dispensaries in California and Illinois and pending retail operations in Illinois and New Jersey. We work daily to increase our market share through delighting customers while also continuing to hone our operational efficiencies to drive profits. We are primarily guided by the metric of return on investment. Currently, we believe the most significant return on investment projects in front of us are successful retail cannabis store launches in Illinois and New Jersey, which augment our existing retail footprint.
Please visit www.bodyandmind.com for more information.
Twitter: @bodyandmindBaM
For further information, please contact:
Company Contact:
Michael Mills
President and CEO
Tel: 800-361-6312
ir@bodyandmind.com
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Safe Harbor Statement
Except for the statements of historical fact contained herein, the information presented in this news release constitutes "forward-looking statements" as such term is used in applicable United States and Canadian laws. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any other statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as "expects" or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans, "estimates" or "intends", or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved) are not statements of historical fact and should be viewed as "forward-looking statements". Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such risks and other factors include, among others, the actual results of activities, variations in the underlying assumptions associated with the estimation of activities, the availability of capital to fund programs and the resulting dilution caused by the raising of capital through the sale of shares, accidents, labor disputes and other risks. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and in any document referred to in this news release.
Certain matters discussed in this news release and oral statements made from time to time by representatives of the Company may constitute forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved. Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company's ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/237763
FAQ
When will Body and Mind (BMMJ) file its 2024 annual financial statements?
What are the remaining steps for BMMJ to complete its 2024 financial audit?
What period do the delayed BMMJ financial statements cover?
What regulatory policy applies to BMMJ's delayed financial filings?
